Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis

Azie, N; Angulo, D; Dehn, B; Sobel, JD

Azie, N (corresponding author), SCYNEXIS Inc, Jersey City, NJ 07302 USA.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020; 29 (9): 893

Abstract

Introduction Vulvovaginal candidiasis (VVC) is a common fungal infection caused by predominantlyCandida albicans, and is diagnosed in up to 40% of wom......

Full Text Link